Critical Reviews in Oncology Hematology
Elsevier Ireland Ltd · United States
Metrics
- Impact factor
- 6.2+0.6 Clarivate JCR
- WoS quartile
- Q1 Clarivate JCR, best category
- SJR
- 1.977Q1 SCImago
- h-index
- 111
- CAS tier
- Tier 2 Chinese Academy of Sciences
- Citations per paper
- 6.71 last 2 years
- Articles per year
- 250
- Self-citation
- 1.8%
- Fee (APC), est.
- $3,660 estimated, check the journal
About this journal
- ISSN
- 1040-8428 (print) · 1879-0461 (online)
- Publisher
- Elsevier Ireland Ltd · Elsevier
- Country
- United States · Western Europe
- Indexed in
- SCIE
- Access
- Hybrid · 31.5% gold OA
- Founded
- 1983
- Frequency
- Monthly
- Original research
- 0%
- Subject areas
- Medicine
- Categories
- Medicine, Hematology
- Common topics
- Medicine, Biology, Internal medicine, Genetics, Cancer
Similar journals
- Q1WoS
New England Journal of Medicine
Impact factor 84.5h-index 933SJR 18.40 - Q1WoS
Lancet
Impact factor 109h-index 700SJR 14.82 - Q1WoS
Jama-Journal of the American Medical Association
Impact factor 65.4h-index 622SJR 5.84 - Q1WoS
Circulation
Impact factor 41.3h-index 570SJR 8.31 - Q1WoS
Bmj-British Medical Journal
Impact factor 55.1h-index 543SJR 1.99 - Q1WoS
Nature Medicine
Impact factor 52.5h-index 497SJR 17.50
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals